Hill's Pet Nutrition, Inc. provides pet food products and pet care services. It offers products to the breeders, veterinarians, and pet supply retailers. The company was founded by Mark L. Morris in 1939 and is headquartered in Topeka, KS.

Oscient Pharmaceuticals Corp. is a biopharmaceutical company that sells and markets products to community-based primary care physicians through its primary care sales force in the United States. It markets two products namely, ANTARA fenofibrate capsules, a cardiovascular product and FACTIVE gemifloxacin mesylate tablets, a fluoroquinolone antibiotic. It also has late-stage antibiotic candidate, Ramoplanin for the treatment of clostridium difficile-associated disease. The company was founded on May 09, 1961 and is headquartered in Waltham, MA.

Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD.

Société des Produits Nestlé SA engages in the manufacture and distribution of food, pharmaceutical, medical, and cosmetic products. The company was founded on December 15, 1936 and is headquartered in Vevey, France.

Trillium Therapeutics Inc. operates as a biopharmaceutical research and development company. It focuses on the immune system and its regulation. The company specializes in the discovery and development of protein therapeutics, such as monoclonal antibodies, secreted proteins, and peptides. It involves in therapeutic areas, including autoimmune disease, cancer, necrotizing enterocolitis, and transplantation. Trillium Therapeutics Inc. was formerly known as Transplantation Technologies Inc. and changed its name in May 2003. The company was founded in 1996 and is based in Toronto, Canada.

Zen-Bio, Inc. operates as a biotechnology company, provides biological products and services. The firm offers research tools for the study of human metabolic diseases; and contract research services for pharmaceutical and biotechnology companies. It also provides primary human peritoneal mesothelial cells for cancer, obesity, and type 2 diabetes research; primary human skeletal myocyte and adipocyte co-culture system for type 2 diabetes and obesity research; primary human tenocyte culture system that is used in investigating new therapies for tendon healing and repair; fatty liver disease model for the wider drug discovery and development community. The company was founded in 1995 and is headquartered in Durham, NC.

Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. It operates through the following business segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Medical Devices segment includes electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care products for people with diabetes, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.

BioMarin develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions. The company's product portfolio comprises three approved products and multiple clinical and pre-clinical product candidates. Approved products include Naglazyme® (galsulfase) for mucopolysaccharidosis VI (MPS VI), a product wholly developed and commercialized by BioMarin; Aldurazyme® (laronidase) for mucopolysaccharidosis I (MPS I), a product which BioMarin developed through a 50/50 joint venture with Genzyme Corporation; and Kuvan® (sapropterin dihydrochloride) Tablets, for phenylketonuria (PKU), developed in partnership with Merck Serono, a division of Merck KGaA of Darmstadt, Germany.

Bristol-Myers Squibb Company, through its subsidiaries, engages in the discovery, development, licensing, manufacturing, marketing, distribution, and sale of pharmaceuticals and nutritional products. The company operates in two segments, Pharmaceuticals, and Nutritionals. The Nutritionals segment is operated through the company's subsidiary Mead Johnson Nutrition Company (Mead Johnson). The Pharmaceuticals segment is made up of the global pharmaceutical and international consumer medicines business.

Nestec SA, a subsidiary of Nestlé SA, is a Swiss company located in Vevey. The firm manufactures nutrition food products.

Smithkline Beecham Plc develops and manufactures pharmaceutical products. The company markets pharmaceuticals for human and animal healthcare consumption, vaccines, over the counter medicines, health related consumer products, clinical laboratory testing services, disease management and pharmaceutical benefit management. It is headquartered in Brentford, UK.

Shijiazhuang Hi-Tech Co., Ltd., established on 2016-04-01, Business scope includes computer software and hardware,Medical technology research and development,technical consulting,technology transfer;computer system integration;data processing;Conference and exhibition service;ceremonial celebration;design,make,Agency for domestic advertising business,Release domestic outdoor advertising business;Enterprise Marketing Planning;Business Management Consulting;Health Management Consulting(treat,Excluding diagnosis and treatment);Computer hardware and software and peripheral auxiliary equipment,medical instruments(The operating permit),Health Supplies,Instrumentation,sporting goods(except crossbow),electronic product,Office Supplies,Healthy food(The operating permit),Pre-packaged food(The operating permit),building materials,Fitness Equipment,plastic products(Except medical plastic products),rubber products(Except medical rubber products)wholesale and retail;Indoor and outdoor decoration engineering design and construction;Stadium design and construction.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Anhui Zhilian Management Consulting Co., Ltd., established on 2009-04-27, Business scope includes business management consulting,high-tech enterprises(product)Certification consultation;Science and technology project declaration agent;patent agency,Trademark agency consultation;Certification body business;Transformation of scientific and technological achievements and appraisal consultation(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments).***

UAB Research Foundation (doing business as UABRF), a subsidiary of The University of Alabama System, is a company headquartered in Birmingham, AL. The firm engages in identify, assess, and market commercially viable technology developed at The University of Alabama at Birmingham.

Cognate Bioservices is a fully-integrated contract bioservices organization providing the highest level of scientific and management expertise. Cognate provides full development and cGMP manufacturing services to companies and institutions engaged in the development of cell-based products. The combination of highly experienced staff, successful track records and cGMP facilities makes Cognate one of the most qualified contract manufacturers of cell-based products in the world today.

Tianjin Zhengtian Medical Equipment Co., Ltd., established on 2003-01-09, Business scope includes licensed projects:Production of Class II Medical Devices;Production of Class III Medical Devices;Class III medical device business;Production of medical masks.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Import and export;Production of Class I Medical Devices;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Medical Mask Retail;Wholesale medical masks;daily mask(non-medical)Sales;daily mask(non-medical)Production;Medical Research and Experimental Development;Manufacturing of hardware products;Manufacturing of forgings and powder metallurgy products;Sales of forgings and powder metallurgy products;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Metal Material Sales;Synthetic Materials Sales.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Founded by world leaders in the field of regenerative medicine, ProChon is a privately-held biotechnology company focused on modulating the fibroblast growth factor system to enable it to create more effective solutions for tissue regeneration. ProChon's products combine cell regeneration technologies with proprietary growth factors and biocompatible scaffolds to restore injured or chronically damaged tissues to normal. ProChon has filed patent applications, licensed patents for core technologies and products, and has been granted patents in the United States, Europe, Israel and Australia. ProChon's R&D facility resides in Ness Ziona, Israel and the executive management team is based in Woburn, Massachusetts.

Établissement Français du Sang collects, prepares, qualifies and distributes blood transfusion products. The company is headquartered in Saint-Denis, France.